Results for “ ”

Entry Author Date Location
Acceleron Drops Drug for Rare Muscle Disease After Mixed Phase 2 Data 03/10/20 Boston
Kala to Take Another Shot at FDA Approval With New Dry Eye Drug Data 03/09/20 Boston
Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod 03/09/20 Europe
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects 03/05/20 San Diego
Culture Biosciences Adds $15M for New Software, Bioreactor Expansion 03/05/20 San Francisco
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets 03/04/20 New York
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
Court Rules More Trial Data Must Be Posted On ClinicalTrials.gov 03/04/20 National
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
Sanofi Wins FDA Nod for Combo Therapy in Multiple Myeloma 03/03/20 National
National Xconomy Awards Now Accepting Nominations for the Best in Biotech 03/03/20 National
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers 03/02/20 San Francisco
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
Biogen, Sangamo Ink Neuro Deal for New “Gene Regulation” Therapies 02/28/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Passage Bio’s IPO Raises $216M to Fund Gene Therapy Studies 02/28/20 National
Biohaven’s Migraine Pill Is the Latest CGRP Drug to Win the FDA’s OK 02/27/20 New York
Gilead, Moderna Candidates Ramp Up Coronavirus Drug, Vaccine Testing 02/27/20 National
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod 02/26/20 Detroit Ann Arbor
Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data 02/26/20 San Diego
With Foamix Merger Weeks Away, Menlo Itching Drug Fails a Phase 2 Test 02/26/20 San Francisco
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System 02/25/20 Europe
Esperion’s FDA-Approved Cholesterol Drug Priced Even Lower Than Expected 02/24/20 Detroit Ann Arbor
NGM Bio’s NASH Drug Shows Promise, Shares Rise on Early Phase 2 Data 02/24/20 San Francisco
Invetx Fetches $15M to Develop Biologic Drugs for Man’s Best Friend 02/24/20 Boston
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
Page 2 of 1962 « previous page · next page »